Lung cancer is a significant health issue, and non-small cell lung cancer (NSCLC) is a common type. One way to fight it is by targeting something called PD-L1, which is often found on lung cancer cells. Blocking PD-L1 can help the body's immune system attack the cancer. This is where aptamers come in. Aptamers are like tiny, smart molecules that can stick to specific...

Nasopharyngeal carcinoma (NPC) is linked to the Epstein-Barr virus (EBV). Immune checkpoint inhibitors (ICIs) are making waves in treating this cancer. When combined with chemotherapy, they're showing promise. This study dug into the immune cell profiles and how they affect survival in metastatic NPC patients treated with ICIs. Researchers looked at 81 tissue samples...